CyberKnife S7 San Diego | Non-Surgical Cancer Treatment with Unmatched Precision
Cutting-Edge Radiation Therapy, Right Here in San Diego
The CyberKnife® S7 System is a breakthrough in non-invasive cancer treatment. It offers pinpoint accuracy, real-time tumor tracking, and shorter treatment times, often completed in just 1–5 sessions.
Now available at Unio Specialty Care Radiation Oncology – San Diego, our team is proud to offer this world-class treatment option to patients in Southern California.
Why Choose CyberKnife S7?
CyberKnife isn’t a knife—it’s a revolutionary robotic radiation system that targets tumors without surgery or hospitalization. With our advanced CyberKnife S7, you benefit from:
- Unmatched Precision: Delivers high-dose radiation directly to tumors, minimizing damage to surrounding healthy tissue.
- Real-Time Tumor Tracking: Uses AI-guided motion tracking for tumors that move (like those in the lungs, liver, or prostate).
- Fewer Treatments: Most patients only require 1 to 5 short outpatient sessions.
- Painless and Non-Invasive: No incisions, no anesthesia, no recovery time.
- Treats Hard-to-Reach or Inoperable Tumors: Especially valuable when surgery is not an option.
- No Invasive Head or Body Frame.
Tumors Treated with CyberKnife S7
- Brain and Spine Tumors (primary and metastatic)
- Prostate Cancer
- Lung Tumors
- Liver Tumors
- Pancreatic Cancer
- Kidney Tumors
- Head and Neck Cancers
- Recurrent Tumors
- Arteriovenous Malformations (AVMs)
- Acoustic Neuroma
- Meningioma
- Trigeminal Neuralgia
Is CyberKnife Right for You?
CyberKnife S7 may be ideal if:
- You have a tumor that is difficult to reach surgically
- You’ve been told surgery isn’t an option
- You want to avoid the risks and recovery time of surgery
- You need a precise and effective treatment for recurring or previously treated cancer
Our team can evaluate your condition and determine if CyberKnife is the best option for you.
What to Expect With CyberKnife Treatment
Step 1: Schedule a Consultation
Meet with one of our experienced radiation oncologists to evaluate whether CyberKnife is appropriate based on the patient’s biopsy results, imaging, and overall health.
Step 2: Defining Target Location
To precisely define the target area, some treatments may require placing small gold markers (fiducials) inside or near the tumor — for example, in the prostate, lung, or liver. In other cases, such as brain or spine tumors, normal anatomy may be enough for tracking. If needed, fiducials are placed during an outpatient procedure similar to a prostate biopsy, usually under conscious sedation about two weeks before treatment begins.
Step 3: Imaging and Treatment Planning
If fiducials are placed, the patient typically returns for imaging about a week later. In other cases, imaging is scheduled as needed. These scans help the radiation team develop a personalized treatment plan based on the patient’s unique anatomy.
Step 4: Treatment Sessions
About a week later, treatment sessions begin. The patient typically undergoes 1–5 short, non-invasive outpatient sessions over 1–2 weeks*. During each session, the patient lies on a treatment table while the CyberKnife® System uses Synchrony® software to track respiratory movement and deliver precise radiation. No anesthesia is required during treatment.
Step 5: Follow-Up & Ongoing Support
After treatment, we’ll monitor your progress and coordinate follow-up care. Our team stays with you every step of the way to ensure the best outcome.
Download the Free CyberKnife® Patient Guide
Considering CyberKnife treatment?
Get your free copy of our comprehensive Patient Information Guide to learn everything you need to know about this advanced, non-invasive option for treating cancerous and benign tumors.
Inside you’ll discover:
- How CyberKnife S7 works—and what makes it so precise
- What to expect before, during, and after treatment
- Conditions commonly treated (brain, prostate, lung, spine, and more)
- Answers to common questions from real patients
- How to know if CyberKnife might be right for you
Fill out the form below and we’ll email you the form immediately:
By submitting this form, you agree to receive occasional email updates with information and resources related to CyberKnife. You can unsubscribe at any time.
What Makes CyberKnife Different?
No Incisions or Hospital Stay
Real-Time Tumor Tracking
Sub-Millimeter Accuracy
Comfortable, Outpatient Sessions
Treatments are fast and non-invasive. Most patients return home right after each session and resume normal activity.
Schedule a CyberKnife Consultation Today
If you or a loved one has been diagnosed with cancer, now is the time to explore your treatment options. CyberKnife offers a non-surgical, highly precise approach that can minimize side effects and help you get back to living your life. Our expert radiation oncology team is here to answer your questions, review your case, and help you determine if CyberKnife is right for you.
Schedule your consultation or download our brochure to learn more.
Frequently Asked Questions About CyberKnife S7
CyberKnife S7 is a non-invasive cancer treatment that uses precise, high-dose radiation to target tumors. Its robotic arm and real-time imaging allow it to track tumor movement — even as you breathe — delivering radiation with sub-millimeter accuracy.
CyberKnife is FDA-cleared to treat many types of tumors, including those in the prostate, lung, brain, spine, liver, pancreas, as well as non-cancerous lesions such as arteriovenous malformations (AVMs), acoustic neuromas, meningiomas and trigeminal neuralgia. It’s especially effective for hard-to-reach or surgically complex tumors.
No. CyberKnife treatment is painless. There are no incisions, no anesthesia, and no recovery time required after each session.
Most patients complete their treatment in 1 to 5 outpatient sessions. Your care team will determine the exact number based on your diagnosis and treatment plan.
Yes. CyberKnife has been used worldwide for over two decades and is backed by extensive clinical research. It’s a trusted option for patients who want effective treatment with fewer side effects.